Autoimmune Disease Diagnostics Market – Global Industry Growth, Segmentation And Forecasts to 2020: Hexa Research
The rising prevalence of autoimmune diseases and consequent increase in healthcare expenditure globally are the major factors driving the autoimmune disease diagnostics market. Moreover, the favorable government initiatives in various countries are also a factor leading to the growth of global autoimmune disease diagnostics market. As stated by NIH, autoimmune disease is one of the top ten causes of women deaths. The active awareness campaigns aimed to increase the awareness level regarding the diagnostics of diseases is the factor expected to further fuel the global autoimmune disease diagnostics market over the forecast period.
Full research report on Global Autoimmune Disease Diagnostics Market with detailed figures and charts available at:
The autoimmune disease diagnostics market on the basis of product is segmented into localized and systemic disease diagnostics. As of 2013, the local disease diagnostics attributed the largest share in the market owing to the relatively higher patient awareness level and the presence of huge procedure volumes. In localized autoimmune disease segment, there are huge unmet needs of the patients for various diseases such as type 1 diabetes. This factor is expected to drive the localized autoimmune disease diagnostics market over the forecast period. The systemic autoimmune disease diagnostics segment include diagnosis of diseases such as lupus erythematosus (SLE), Ankylosing Spondylitis and rheumatoid.
Key points from the study:
The rheumatoid segment attributes the largest share in the market owing to its most commonly usage in the diagnosis of autoimmune systemic inflammatory diseases. The entanglement of expensive organ assessment test in the rheumatoid disease is also a factor driving the systemic autoimmune rheumatoid disease diagnostics market.
North America covered the largest share in the autoimmune disease diagnostics market in terms of revenue. The existence of favorable government initiatives such as Patient protection Act and Affordable Care Act and enlightened healthcare infrastructure are some other factors driving the market in this region. According to NIH, North America is accounted for the largest annual expenditure in autoimmune disease diagnostics market.
Europe is accounted for the second largest market as of 2013. The technological advances in autoimmune disease diagnosis such as novel biomarkers and potable diagnostic equipments and increasing incidences of autoimmune diseases are the key factors for the growth of autoimmune disease diagnostics market in this region. The factor expected for the further growth of this region is the huge untapped opportunities mainly in the Eastern Europe.
Get more information on Global Autoimmune Disease Diagnostics Market or request for sample of this research report at:
Key companies analyzed:
About Hexa Research:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
For more information, visit: www.hexaresearch.com/
Related Reports By Hexa Research:
Home Healthcare Market:
Medical Robotic Systems Market:
Company Name: Hexa Research Contact Person: Michelle Thoras Email: firstname.lastname@example.org Phone: +1-800-489-3075+1-800-489-3075 FREE Address:Felton Office Plaza, 6265 Highway 9 City: Felton State: California Country: United States Website: www.hexaresearch.com/research-report/autoimmune-disease-diagnostics-market-size-market-share-application-analysis-regional-outlook-growth-trends-competitive-scenario-and-forecasts-2012-to-2020/